Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Grant

Showing results (501-510 of 545) with videos related to

Pageof 55
Sort By:
Physical & Occupational Therapy in Pediatrics|October 31, 2022
The Burden of COVID-19 on Caregivers of Children with Suspected Genetic Conditions: A Therapeutic OdysseyMargaret Waltz, Courtney Canter, Jeannette T Bensen, et al.
Orphanet Journal of Rare Diseases|May 7, 2024
Disease characteristics, effectiveness, and safety of vestronidase alfa for the treatment of patients with mucopolysaccharidosis VII in a novel, longitudinal, multicenter disease monitoring programRoberto Giugliani, Antonio Gonzalez-Meneses, Maurizio Scarpa, et al.
Science Translational Medicine|April 9, 2010
Safety and efficacy of subretinal readministration of a viral vector in large animals to treat congenital blindnessDefne Amado, Federico Mingozzi, Daniel Hui, et al.
Journal of Translational Medicine|March 4, 2025
Analysis of the measurements used as potency tests for the 31 US FDA-approved cell therapy productsCarl G Simon, Erich H Bozenhardt, Christina M Celluzzi, et al.
Journal of Translational Medicine|May 2, 2024
Mechanism of action, potency and efficacy: considerations for cell therapiesCarl G Simon, Erich H Bozenhardt, Christina M Celluzzi, et al.
Development (Cambridge, England)|September 22, 2021
The histone acetyltransferase HBO1 promotes efficient tip cell sprouting during angiogenesisZoe L Grant, Peter F Hickey, Waruni Abeysekera, et al.
Personalized Medicine|October 7, 2020
Engaging community stakeholders in research on best practices for clinical genomic sequencingIda Griesemer, Brooke S Staley, Alexandra F Lightfoot, et al.
Environment International|February 1, 2016
Approaches for describing and communicating overall uncertainty in toxicity characterizations: U.S. Environmental Protection Agency's Integrated Risk Information System (IRIS) as a case studyNancy B Beck, Richard A Becker, Neeraja Erraguntla, et al.
Biorxiv : the Preprint Server for Biology|January 20, 2025
Dose-dependent sensitivity of human 3D chromatin to a heart disease-linked transcription factorZoe L Grant, Shuzhen Kuang, Shu Zhang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 2, 2022
An international, open-label, randomised trial comparing a two-step approach versus the standard three-step approach of the WHO analgesic ladder in patients with cancerM Fallon, K Dierberger, M Leng, et al.
Pageof 55

Showing results (501-510 of 545) with videos related to

Sort By:
Pageof 55
Physical & Occupational Therapy in Pediatrics|October 31, 2022
The Burden of COVID-19 on Caregivers of Children with Suspected Genetic Conditions: A Therapeutic OdysseyMargaret Waltz, Courtney Canter, Jeannette T Bensen, et al.
Orphanet Journal of Rare Diseases|May 7, 2024
Disease characteristics, effectiveness, and safety of vestronidase alfa for the treatment of patients with mucopolysaccharidosis VII in a novel, longitudinal, multicenter disease monitoring programRoberto Giugliani, Antonio Gonzalez-Meneses, Maurizio Scarpa, et al.
Science Translational Medicine|April 9, 2010
Safety and efficacy of subretinal readministration of a viral vector in large animals to treat congenital blindnessDefne Amado, Federico Mingozzi, Daniel Hui, et al.
Journal of Translational Medicine|March 4, 2025
Analysis of the measurements used as potency tests for the 31 US FDA-approved cell therapy productsCarl G Simon, Erich H Bozenhardt, Christina M Celluzzi, et al.
Journal of Translational Medicine|May 2, 2024
Mechanism of action, potency and efficacy: considerations for cell therapiesCarl G Simon, Erich H Bozenhardt, Christina M Celluzzi, et al.
Development (Cambridge, England)|September 22, 2021
The histone acetyltransferase HBO1 promotes efficient tip cell sprouting during angiogenesisZoe L Grant, Peter F Hickey, Waruni Abeysekera, et al.
Personalized Medicine|October 7, 2020
Engaging community stakeholders in research on best practices for clinical genomic sequencingIda Griesemer, Brooke S Staley, Alexandra F Lightfoot, et al.
Environment International|February 1, 2016
Approaches for describing and communicating overall uncertainty in toxicity characterizations: U.S. Environmental Protection Agency's Integrated Risk Information System (IRIS) as a case studyNancy B Beck, Richard A Becker, Neeraja Erraguntla, et al.
Biorxiv : the Preprint Server for Biology|January 20, 2025
Dose-dependent sensitivity of human 3D chromatin to a heart disease-linked transcription factorZoe L Grant, Shuzhen Kuang, Shu Zhang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 2, 2022
An international, open-label, randomised trial comparing a two-step approach versus the standard three-step approach of the WHO analgesic ladder in patients with cancerM Fallon, K Dierberger, M Leng, et al.
Pageof 55